Skip to content

Insights

Within 3 years 92% of startups fail.

Learn from their mistakes.

We don’t shy away from providing you with an outsider’s view of your business.

It is critical to your success.

The percentage of startups that fail can vary significantly depending on the source, but a commonly cited statistic is that around 90% of startups fail. The exact percentage can differ based on the industry, market conditions, and geographical location.

Here’s a general breakdown of startup failure rates by various business sectors:

Overall startup failure rate

  • General failure rate: ~90% of all startups fail.
  • First-year failure rate: Approximately 10% of startups fail within the first year.
  • Five-year failure rate: Around 50% fail by the fifth year.
  • Ten-year failure rate: About 70% of startups fail within ten years.

Failure rates by area

Healthcare and biotech

  • Failure rate: ~80%
  • Reasons: Extensive regulatory requirements, long product development cycles, and high capital needs make it challenging.

Technology

  • Failure rate: ~63%
  • Reasons: High competition, rapid technological advancements, and significant R&D costs contribute to the high failure rate.

We have a proven track record of helping healthcare startups avoid common pitfalls and achieve success.

Chart showing the ten most common reasons startups fail, based on 300 startup postmortems

  • No market need: We validate your product ideas through comprehensive market analysis, ensuring alignment with real-world healthcare demands.
  • Ran out of cash: We format startups to become attractive to investors and grant authorities, preventing cash flow issues.
  • Not the right team: We can help build balanced teams with the necessary expertise and cohesion to drive your startup forward.
  • Got outcompeted: Based on sound market insights, we help you understand how to strategically position your specific technology to keep your startup ahead of competitors.
  • Pricing/cost issues: We help you develop pricing strategies in the different medical market segments that ensure profitability while remaining competitive in the healthcare market.
  • Poor product: We assist in refining products to meet the highest standards of quality and user needs, reducing the risk of poor market reception.
  • Lack of a business model: We help you refine your business model to the complexities of the healthcare industry.
  • Poor marketing: While we don’t do marketing, we help you conduct marketable pilot projects that help drive adoption and growth.
  • Ignore customers: We never work without feedback from doctors, patients, payors and industry experts, ensuring your product evolves in line with user needs and expectations.
  • Product mis-timed: We help you identify healthcare megatrends to ensure your product is not struggling against the current.

Conclusion: failure is rarely caused by one decision

Healthcare innovation projects seldom fail because of a single dramatic mistake. More often, clinical need, evidence, regulation, product development, financing, market positioning and team capabilities gradually move out of alignment. A promising technology can therefore remain scientifically interesting while becoming commercially fragile or difficult to adopt.

The practical lesson is to examine these dependencies early and repeatedly. Assumptions should be challenged while there is still time to adjust the product, evidence plan, organisation or route to market. An experienced outside perspective can make those connections visible before individual risks reinforce one another.

Turn uncertainty into better decisions

If you are developing a medical device, diagnostic or digital health solution, Quint Healthcare can help you test the critical assumptions, connect the clinical and business perspectives and define pragmatic next steps.

Discuss your project